Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-04-11 @ 7:02 PM
Study NCT ID:
NCT06627257
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-10-04
First Post:
2023-08-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy
Sponsor:
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ASCLIN 001/2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |